Nine presentations made during the public comment period representing members of the Endocrine Policy Forum, American Chemistry Council, CropLife America
Document Subtype:
Company/Organization Comment
Received Date:
January 30 2013, at 12:00 AM Eastern Standard Time
Page Count:
1
Attachments:
Slide show entitiled "Prioritization of the Endocrine Disruptor Screening Program"
View Attachment:
Title: Slide show entitiled "Prioritization of the Endocrine Disruptor Screening Program"
Abstract: This document can be viewed at the USEPA Docket Center, Public Reading Room.
Address: USEPA West
1301 Constitution Ave, NW
Room 3334
Washington, DC 20004
Telephone: 202-566-1744
Fax: 566-9744
Email: docket-customerservice@epa.gov
Slide show entitled "Charge Questions #2 and #3"
View Attachment:
Title: Slide show entitled "Charge Questions #2 and #3"
Slide show entitled "Comments on EPA’s Universe of Chemicals Subject to EDSP Prioritization"
View Attachment:
Title: Slide show entitled "Comments on EPA’s Universe of Chemicals Subject to EDSP Prioritization"
Slide show entitled "Endocrine Policy Forum Comments to the FIFRA SAP Regarding Concordance of Toxcast Highthrougput Assays With EDSP Tier 1 Data"
View Attachment:
Title: Slide show entitled "Endocrine Policy Forum Comments to the FIFRA SAP Regarding Concordance of Toxcast Highthrougput Assays With EDSP Tier 1 Data"
Slide show entitled "ER Expert System, Hight-hroughput Screening (HTS) and Prioritization for EDSP”
View Attachment:
Title: Slide show entitled "ER Expert System, Hight-hroughput Screening (HTS) and Prioritization for EDSP”
Slide show entitled "Evaluating high throughput in vitro assay performance using reference chemicals "
View Attachment:
Title: Slide show entitled "Evaluating high throughput in vitro assay performance using reference chemicals "
Slide show entitled “Analysis of ER Expert Training Set and HTP in vitro Assay Data”
View Attachment:
Title: Slide show entitled “Analysis of ER Expert Training Set and HTP in vitro Assay Data”
Slide show titled "Comments Regarding Availability of the SAP Documents and EPA Communication Plan"
View Attachment:
Title: Slide show titled "Comments Regarding Availability of the SAP Documents and EPA Communication Plan"
Slide show titled “Prioritization Of The Endocrine Disruptor Screening Program Universe Of Chemicals For An Estrogen Receptor Adverse Outcome Pathway Using Computational Toxicology Tools”
View Attachment:
Title: Slide show titled “Prioritization Of The Endocrine Disruptor Screening Program Universe Of Chemicals For An Estrogen Receptor Adverse Outcome Pathway Using Computational Toxicology Tools”
Details Information
Attachments:
Slide show entitiled "Prioritization of the Endocrine Disruptor Screening Program"
View Attachment:Slide show entitled "Charge Questions #2 and #3"
View Attachment:Slide show entitled "Comments on EPA’s Universe of Chemicals Subject to EDSP Prioritization"
View Attachment:Slide show entitled "Endocrine Policy Forum Comments to the FIFRA SAP Regarding Concordance of Toxcast Highthrougput Assays With EDSP Tier 1 Data"
View Attachment:Slide show entitled "ER Expert System, Hight-hroughput Screening (HTS) and Prioritization for EDSP”
View Attachment:Slide show entitled "Evaluating high throughput in vitro assay performance using reference chemicals "
View Attachment:Slide show entitled “Analysis of ER Expert Training Set and HTP in vitro Assay Data”
View Attachment:Slide show titled "Comments Regarding Availability of the SAP Documents and EPA Communication Plan"
View Attachment:Slide show titled “Prioritization Of The Endocrine Disruptor Screening Program Universe Of Chemicals For An Estrogen Receptor Adverse Outcome Pathway Using Computational Toxicology Tools”
View Attachment:Comments
Related Documents